✦ LIBER ✦

PDG1: THE OUTCOMES OF LONG-TERM TREATMENT OF A NEW ORAL DIABETES DRUG PIOGLITAZONE (ACTOS **) IN THE MANAGEMENT OF TYPE 2 DIABETES IN FINLAND

✍ Scribed by N Maniadakis; A Kielhorn; K Heikkinen; A Brandt; R Jansen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDG11: HEALTH AND ECONOMIC OUTCOMES OF A

✍ A Brandt; K Frislid; R Jansen; N Maniadakis; A Kielhorn 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PDG6: COST-EFFECTIVENESS OF PIOGLITAZONE

✍ F Henriksson; A Brandt; L Thomander; A Kielhorn; R Jansen; N Maniadakis 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PDG14: AN ASSESSMENT OF THE COSTEFFECTIV

✍ R Jansen; JO Clausen; N Maniadakis; A Kielhorn; A Brandt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

The effect of a long term structured dia

✍ Wenhui Li; Heng Wang 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 277 KB

PDG10: A PHARMACOECONOMIC MODEL OF HbA1c

✍ H Lilliu; J Bonastre; L Cabrieres 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

985 THE IMPACT OF LONG-TERM PIOGLITAZONE

✍ P.M. Yeap; K.A. Lockman; M. Boyd; A.J. Jaap; P.C. Hayes 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB